Pacific Biosciences of California Inc

NASDAQ:PACB   11:57:49 AM EDT
35.43
+3.30 (+10.27%)
Other Pre-Announcement

Pacific Biosciences Signs Definitive Agreement To Acquire Omniome

Published: 07/20/2021 13:01 GMT
Pacific Biosciences of California Inc (PACB) - Pacific Biosciences Signs Definitive Agreement to Acquire Omniome.
Transaction Supported by Concurrent $300 Million Pipe Financing From Premier Life Science Investors.
Will Acquire Omniome for Upfront Consideration of Approximately $600 Million.
Overall Transaction Valued at About $800 Million.
Sees Preliminary Revenue of Approximately $30.5 Million for Q2 of 2021.
Q2 Revenue View $29.9 Million -- Refinitiv Ibes Data (analyst estimates).